Table 1.
Site of action, doses and vehicles used for the NMDA site-selective drugs tested in rats trained to discriminate PCP or NPC 17742 from saline. NT = not tested.
Drug | NMDA Receptor Site of Action |
Doses Tested (mg/kg, i.p.) | Vehicle | |
---|---|---|---|---|
PCP-trained | NPC17742- Trained |
|||
PCP | Channel site antagonist | 0.5, 1, 2, 4, 8 | NT | Saline |
NPC 17742 | NMDA-site antagonist | NT | 1, 2, 4, 16 | Saline1 |
MDL 100,458 | Glycine-site antagonist | 3, 10, 30, 56, 75 | NT | 0.1% Tween-80 |
MDL 100,748 | Glycine-site antagonist | 1, 1.7, 3 | NT | 0.1% Tween-80 |
MDL 103,371 | Glycine-site antagonist | 3, 10, 15.6, 30, 56 | 15.6, 30, 56, 100 | Water2 |
MDL 104,472 | Glycine-site antagonist | 10, 15.6, 30, 56 | 3, 10, 15.6 | Water2 |
MDL 105,519 | Glycine-site antagonist | 5.6, 10, 15.6, 30, 56, 100 |
5.6, 10, 15.6, 30 | 0.1% Tween-80 |
MRZ 2/571 | Glycine-site antagonist | 3, 5.6, 10, 17 | 3, 5.6, 10, 17 | Water |
MRZ 2/576 | Glycine-site antagonist | 1, 3, 5.6, 10 | 3, 5.6, 10, 17 | Water |
ACEA-0762 | Glycine-site antagonist | 0.3, 1, 3 | 0.3, 1, 3, 5.6 | DMSO |
L 701,324 | Glycine-site antagonist | 1, 3, 5.6, 10, 17.6 | 1, 3, 5.6, 10 | 25% PEG/ DMSO3 |
ACPCM | Glycine-site partial agonist | 30, 100, 300 | NT | Water |
(+)-HA-966 | Glycine-site partial agonist | 3, 10, 30, 56 | NT | Water |
First solubilized in water with equimolar NaOH to a concentration of 80 mg/ml then diluted to the desired concentration in saline.
First combined with 2 mEq NaOH then diluted with water and titrated to neutral pH with 1 N HCl to achieve the desired concentration.
25% polyethylene glycol vehicle used for testing L701, 324 in PCP-trained rats; DMSO vehicle used for testing L 701,324 in NPC 17742-trained rats.